The House Committee on Veterans Affairs voted in support of medical cannabis access and research, sending two bills to the full House.
The FDA is reopening public comment, collaborating with global regulators on how to handle cannabinoids, and backing research on CBD and “dermal penetration.”
DEA says legislation pending White House approval would pave the way for new, federally-approved research-grade cannabis farms.
Crapo laid out “significant concerns” about the SAFE Banking Act on Wednesday, suggesting a 2% THC cap on products eligible for financial services.
The MORE Act, which the House Judiciary Committee passed Wednesday, is the first legalization bill to get a Congressional vote.
The Act would deschedule and legalize cannabis with strong equity provisions, from expungement to opening up loan programs for small business owners.
Sen. Diane Feinstein asked if vaping can “bring on death” as lawmakers consider publishing a paper on the health impacts of cannabis.
The bipartisan legislation passed 321-103, and now heads to the Senate.
Lawmakers say the bill, which has strong bi-partisan support and 206 co-sponsors, has enough votes to pass.
The bill will “allow rural entrepreneurs an opportunity to start to grow their businesses and create much-needed jobs,” Oregon Sen. Jeff Merkley said during a Senate Appropriations Committee hearing Thursday.
“This anti-immigrant agenda from the Trump administration stands in contrast to the policies of dozens of states that have legalized or decriminalized marijuana.”
The push could give CBD-based food additives and dietary supplements the green light.
There are close to sixty cannabis-related bills pending consideration in Congress, and some have serious support.
Officials from three federal agencies updated a Senate committee on their progress in drafting regulations for hemp production and products.
Both advocates and enemies of the SAFE Banking Act got to make their case.
Lawmakers and witnesses argue that done properly, legalization could right some historic wrongs.